VAERS reports by lot

GSK DTaP/Tdap lot X357E: VAERS reports

21 VAERS reports list lot X357E as a GSK DTaP/Tdap vaccine, received between 2024-07-15 and 2024-12-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
0%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1227%
Injection-site / Local reaction1227%
Cardiac / Cardiovascular614%
Dermatological (non-injection-site)49%
General / Systemic (non-local)49%
Respiratory25%
Musculoskeletal25%
Gastrointestinal12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida5
Pennsylvania3
California2
Texas1
Georgia1
Washington1
Ohio1
District of Columbia1
New York1
Tennessee1
Michigan1
Illinois1

Reports by month received

2024-072
2024-084
2024-097
2024-102
2024-112
2024-124

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.